X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
34
PharmaCompass offers a list of Ciprofloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ciprofloxacin manufacturer or Ciprofloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ciprofloxacin manufacturer or Ciprofloxacin supplier.
PharmaCompass also assists you with knowing the Ciprofloxacin API Price utilized in the formulation of products. Ciprofloxacin API Price is not always fixed or binding as the Ciprofloxacin Price is obtained through a variety of data sources. The Ciprofloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ciprofloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciprofloxacin, including repackagers and relabelers. The FDA regulates Ciprofloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciprofloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ciprofloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ciprofloxacin supplier is an individual or a company that provides Ciprofloxacin active pharmaceutical ingredient (API) or Ciprofloxacin finished formulations upon request. The Ciprofloxacin suppliers may include Ciprofloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of Ciprofloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ciprofloxacin DMF (Drug Master File) is a document detailing the whole manufacturing process of Ciprofloxacin active pharmaceutical ingredient (API) in detail. Different forms of Ciprofloxacin DMFs exist exist since differing nations have different regulations, such as Ciprofloxacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ciprofloxacin DMF submitted to regulatory agencies in the US is known as a USDMF. Ciprofloxacin USDMF includes data on Ciprofloxacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ciprofloxacin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ciprofloxacin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ciprofloxacin Drug Master File in Japan (Ciprofloxacin JDMF) empowers Ciprofloxacin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ciprofloxacin JDMF during the approval evaluation for pharmaceutical products. At the time of Ciprofloxacin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ciprofloxacin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ciprofloxacin Drug Master File in Korea (Ciprofloxacin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ciprofloxacin. The MFDS reviews the Ciprofloxacin KDMF as part of the drug registration process and uses the information provided in the Ciprofloxacin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ciprofloxacin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ciprofloxacin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ciprofloxacin suppliers with KDMF on PharmaCompass.
A Ciprofloxacin CEP of the European Pharmacopoeia monograph is often referred to as a Ciprofloxacin Certificate of Suitability (COS). The purpose of a Ciprofloxacin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ciprofloxacin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ciprofloxacin to their clients by showing that a Ciprofloxacin CEP has been issued for it. The manufacturer submits a Ciprofloxacin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ciprofloxacin CEP holder for the record. Additionally, the data presented in the Ciprofloxacin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ciprofloxacin DMF.
A Ciprofloxacin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ciprofloxacin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ciprofloxacin suppliers with CEP (COS) on PharmaCompass.
A Ciprofloxacin written confirmation (Ciprofloxacin WC) is an official document issued by a regulatory agency to a Ciprofloxacin manufacturer, verifying that the manufacturing facility of a Ciprofloxacin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ciprofloxacin APIs or Ciprofloxacin finished pharmaceutical products to another nation, regulatory agencies frequently require a Ciprofloxacin WC (written confirmation) as part of the regulatory process.
click here to find a list of Ciprofloxacin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ciprofloxacin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ciprofloxacin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ciprofloxacin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ciprofloxacin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ciprofloxacin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ciprofloxacin suppliers with NDC on PharmaCompass.
Ciprofloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ciprofloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ciprofloxacin GMP manufacturer or Ciprofloxacin GMP API supplier for your needs.
A Ciprofloxacin CoA (Certificate of Analysis) is a formal document that attests to Ciprofloxacin's compliance with Ciprofloxacin specifications and serves as a tool for batch-level quality control.
Ciprofloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Ciprofloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ciprofloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Ciprofloxacin EP), Ciprofloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ciprofloxacin USP).
Market Place
